Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma
As a clinical setting in which novel treatment options are urgently needed, hepatocellular carcinoma (HCC) exhibits intriguing opportunities for oncolytic virotherapy. Here we report the rational generation of a novel herpes simplex virus type 1 (HSV-1)-based oncolytic vector for targeting HCC, name...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019-12-01
|
| Col·lecció: | Molecular Therapy: Oncolytics |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2372770519300889 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|